News

All of our latest updates

Press releases

News

January 23, 2020
The first clinical trial data from 13 pancreatic cancer patients treated with LOAd703 and standard of care chemotherapy was presented at GI ASCO San Fransciso. The full study Arm 1 with 18 response evaluable patients will be presented late 2021/early 2022. Arm 2 combining LOAd703, chemotherapy and checkpoint inhibition has begun to enroll patients.
October 20, 2018
Jessica Wenthe from Uppsala University presented Lokon Pharma's research at the European Society for Medical Oncology (ESMO) in Munich and was awarded the Best Poster in the immunotherapy session. Congratulations Jessica!
April 27, 2018
The first patient has been enrolled in the LOAd703 clinical trial in Sweden, LOKON002, for the treatment of pancreatic, biliary, colorectal, and ovarian cancer.

Media

Malou efter 10
Bengt fick aggressiv cancer - hade ett år kvar att leva
Barncancerfonden
Immunterapi på 100 sekunder
Malou efter 10
Forskarna om cancervaccinet: ”Behövs pengar”
Uppsala universitet
Immunterapi är ett nytt sätt att bekämpa cancer.
Forskarpodden
Virus som dödar cancer